Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC37A4 |
| Upstream (Parents) |
|---|
| (<<) GBA3 → SLC37A4 |
| (<<) HRSP12 → SLC37A4 |
| Downstream (Children) |
|---|
| SLC37A4 → NRTN (>>) |
| SLC37A4 → CDHR5 (>>) |
| SLC37A4 → CYP2B7P1///CYP2B6 (>>) |
| SLC37A4 → HNF4A (>>) |
| SLC37A4 → ELOVL4 (>>) |
| SLC37A4 → GUCA2B (>>) |
| SLC37A4 → ALDH5A1 (>>) |
| SLC37A4 → ARHGAP22 (>>) |
| SLC37A4 → KIAA1024 (>>) |
| SLC37A4 → NR5A2 (>>) |
| SLC37A4 → CYP2B7P1 (>>) |
| SLC37A4 → FZD2 (>>) |
| SLC37A4 → MMP26 (>>) |
| SLC37A4 → KREMEN2 (>>) |
| SLC37A4 → XDH (>>) |
| SLC37A4 → TPBG (>>) |
| SLC37A4 → CLDN1 (>>) |
| SLC37A4 → UNC13A (>>) |
| SLC37A4 → ACY1 (>>) |
| SLC37A4 → DGCR2 (>>) |
| SLC37A4 → CXCR4 (>>) |
| SLC37A4 → OXCT1 (>>) |
| SLC37A4 → NIPSNAP1 (>>) |
| SLC37A4 → DAK (>>) |
| SLC37A4 → HSDL2 (>>) |
| SLC37A4 → PTP4A1 (>>) |
| SLC37A4 → ALDH1B1 (>>) |
| SLC37A4 → SLC2A4RG (>>) |
